AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease
NCT: NCT07512206 · NOT_YET_RECRUITING
Brief Summary
The AERO CAD study is a prospective, multi-center, single-arm, post-market clinical investigation evaluating the procedural performance and clinical outcomes of the Shockwave C2 Aero Coronary Intravascular Lithotripsy (IVL) System in patients with calcified coronary artery disease undergoing percutaneous coronary intervention (PCI). The study will enroll up to 200 subjects across up to 8 U.S. sites. The primary objective is to generate real-world evidence on device performance and clinical outcomes, including target lesion failure at 30 days and procedural success.
Frequently Asked Questions
What is AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease?
AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease is a clinical trial registered under NCT07512206. Current status: NOT_YET_RECRUITING.
What is the status of NCT07512206?
The current status of NCT07512206 (AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease) is: NOT_YET_RECRUITING.
When did AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease start?
AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease started on 2026-04-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.